Zefia Horhey

Bachelor of Medicine and Bachelor of Science,  Toronto General - University Health Network 

Location: India

Consulting Services

Scientific Writing Journal Manuscript Admin and Customer Support

Areas Of Interest

Sickness, Sweating Dimethylpolysiloxane Cilazapril, Anhydrous Nova Scotia Niemann-Pick Disease (Type D) Xylanase A Rural Developments Stays, Hospital Infusion Pumps Isoleucine tRNA Ligase Congenital Toxoplasmoses Thermal Water Pollution Thrombocytopoieses Abundant Src Homology Protein Enterocolitides Calculus, Dental Vesicles, COP-Coated Systems, SOS Transcription Factor, Goosecoid Phenylenediamines Situs Inversus with Levocardia Outpatient Service Fever, Pharyngo-Conjunctival Fascicle, Posterior gamma Caseins Docetaxel Synaptotagmin 12 Isovaleryl Coenzyme A Dehydrogenase Embryo Death Receptors, Toll-Like Sch30500 Deiters Nucleus

Professional Narrative

Dr. Zefia Horhey was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Horhey has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Mayo Clinic 1994
Director Medicine, Mayo Clinic 1995

Education

Master of Science in physician assistant, Yale School of Medicine 1996
Doctor of osteopathic medicine, Baylor College 1987

Referees


Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :